Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunityJulia Niessl, Daniel E. Kaufmann, Amy E. Baxter et al.|Nature Medicine|2020Cited by 164
Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19Sebastian J. Theobald, Jan Rybniker, Theodoros Georgomanolis et al.|EMBO Molecular Medicine|2021Cited by 154
Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosaAlexander Simonis, Jan Rybniker, Christoph Kreer et al.|Cell|2023Cited by 55
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralizationTimm Weber, Florian Klein|Immunity|2022Cited by 53
The SARS-CoV-2 spike protein primes inflammasome-mediated interleukin-1- beta secretion in COVID-19 patient-derived macrophagesSebastian J. Theobald, Jan Rybniker, Alexander Simonis et al.|Research Square|2020Cited by 19